The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update
Open accessAbstract
CYP2C19 catalyzes the bioactivation of the antiplatelet prodrug clopidogrel, and CYP2C19 genotype impacts clopidogrel active metabolite formation. CYP2C19 intermediate and poor metabolizers who receive clopidogrel experience reduced platelet inhibition and increased risk for major adverse cardiovascular and cerebrovascular events. This guideline is an update to the 2013 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for the use of clopidogrel based on CYP2C19 genotype and includes expanded indications for CYP2C19 genotype‐guided antiplatelet therapy, increased strength of recommendation for CYP2C19 intermediate metabolizers, updated CYP2C19 genotype to phenotype translation, and evidence from an expanded literature review (updates at www.cpicpgx.org).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
Collet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa575 · Cited by 5,037
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
Shuldiner, A. R. (2009) · JAMA · doi:10.1001/jama.2009.1232 · Cited by 1,505
Self-citationMega, J. L., Simon, T., Collet, J.-P., Anderson, J. L., Antman, E. M., Bliden, K., Cannon, C. P., Danchin, N., Giusti, B., Gurbel, P., et al. (2010) · JAMA · doi:10.1001/jama.2010.1543 · Cited by 1,135
Self-citationAmsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000134 · Cited by 1,059
Self-citationScott, S. A., Sangkuhl, K., Stein, C. M., Hulot, J.-S., Mega, J. L., Roden, D. M., Klein, T. E., Sabatine, M. S., Johnson, J. A., & Shuldiner, A. R. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.105 · Cited by 962
Self-citationKazui, M., Nishiya, Y., Ishizuka, T., Hagihara, K., Farid, N. A., Okazaki, O., Ikeda, T., & Kurihara, A. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.029132 · Cited by 835
Wallentin, L., James, S., Storey, R. F., Armstrong, M., Barratt, B. J., Horrow, J., Husted, S., Katus, H., Steg, P. G., Shah, S. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61274-3 · Cited by 799
A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI
Claassens, D. M. F., Vos, G. J. A., Bergmeijer, T. O., Hermanides, R. S., van ’t Hof, A. W. J., van der Harst, P., Barbato, E., Morisco, C., Tjon Joe Gin, R. M., Asselbergs, F. W., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907096 · Cited by 654
Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Hockett, R. D., Brandt, J. T., Walker, J. R., Antman, E. M., Macias, W. L., Braunwald, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.851949 · Cited by 651
Self-citationSibbing, D., Koch, W., Gebhard, D., Schuster, T., Braun, S., Stegherr, J., Morath, T., Schömig, A., von Beckerath, N., & Kastrati, A. (2010) · Circulation · doi:10.1161/circulationaha.109.885194 · Cited by 585
Collet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4418 · Cited by 562
Pereira, N. L., Farkouh, M. E., So, D., Lennon, R., Geller, N., Mathew, V., Bell, M., Bae, J.-H., Jeong, M. H., Chavez, I., et al. (2020) · JAMA · doi:10.1001/jama.2020.12443 · Cited by 424
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
Wang, Y., Meng, X., Wang, A., Xie, X., Pan, Y., Johnston, S. C., Li, H., Bath, P. M., Dong, Q., Xu, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2111749 · Cited by 395
Mega, J. L., Hochholzer, W., Frelinger, A. L., Kluk, M. J., Angiolillo, D. J., Kereiakes, D. J., Isserman, S., Rogers, W. J., Ruff, C. T., Contant, C., et al. (2011) · JAMA · doi:10.1001/jama.2011.1703 · Cited by 383
Self-citationGimbel, M., Qaderdan, K., Willemsen, L., Hermanides, R., Bergmeijer, T., de Vrey, E., Heestermans, T., Tjon Joe Gin, M., Waalewijn, R., Hofma, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30325-1 · Cited by 357
Cavallari, L. H., Lee, C. R., Beitelshees, A. L., Cooper-DeHoff, R. M., Duarte, J. D., Voora, D., Kimmel, S. E., McDonough, C. W., Gong, Y., Dave, C. V., et al. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.07.022 · Cited by 313
Self-citationPan, Y., Chen, W., Xu, Y., Yi, X., Han, Y., Yang, Q., Li, X., Huang, L., Johnston, S. C., Zhao, X., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024913 · Cited by 281
Galli, M., Benenati, S., Capodanno, D., Franchi, F., Rollini, F., D'Amario, D., Porto, I., & Angiolillo, D. J. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00533-x · Cited by 244
Recommendations for Clinical CYP2C19 Genotyping Allele Selection
Pratt, V. M., Del Tredici, A. L., Hachad, H., Ji, Y., Kalman, L. V., Scott, S. A., & Weck, K. E. (2018) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.01.011 · Cited by 222
Self-citationDerivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel
Angiolillo, D. J., Capodanno, D., Danchin, N., Simon, T., Bergmeijer, T. O., ten Berg, J. M., Sibbing, D., & Price, M. J. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.01.226 · Cited by 170
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy
Pereira, N. L., Rihal, C., Lennon, R., Marcus, G., Shrivastava, S., Bell, M. R., So, D., Geller, N., Goodman, S. G., Hasan, A., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.01.024 · Cited by 166
Botton, M. R., Whirl‐Carrillo, M., Tredici, A. L. D., Sangkuhl, K., Cavallari, L. H., Agúndez, J. A. G., Duconge-Soler, J., Lee, M. T. M., Woodahl, E. L., Claudio‐Campos, K., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1973 · Cited by 157
Self-citationSorich, M. J., Rowland, A., McKinnon, R. A., & Wiese, M. D. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000669 · Cited by 127
Dayoub, E. J., Seigerman, M. E., Tuteja, S., Kobayashi, T., Kolansky, D. M., Giri, J. S., & Groeneveld, P. W. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.0783 · Cited by 123
Lewis, J. P., Backman, J., Reny, J., Bergmeijer, T. O., Mitchell, B. D., Ritchie, M. D., Déry, J., Pakyz, R. E., Gong, L., Ryan, K. A., et al. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz045 · Cited by 100
Self-citationXi, Z., Fang, F., Wang, J., AlHelal, J., Zhou, Y., & Liu, W. (2017) · Platelets · doi:10.1080/09537104.2017.1413178 · Cited by 67
Karve, A. M., Seth, M., Sharma, M., Lalonde, T. A., Dixon, S. R., Wohns, D., & Gurm, H. S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.02.049 · Cited by 59
Verma, S. S., Bergmeijer, T. O., Gong, L., Reny, J., Lewis, J. P., Mitchell, B. D., Alexopoulos, D. K., Aradi, D., Altman, R. B., Bliden, K. P., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1911 · Cited by 57
Self-citationLee, C. R., Thomas, C. D., Beitelshees, A. L., Tuteja, S., Empey, P. E., Lee, J. C., Limdi, N. A., Duarte, J. D., Skaar, T. C., Chen, Y., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2039 · Cited by 54
Self-citationZhang, L., Yang, J., Zhu, X., Wang, X., Peng, L. H., Li, X., Cheng, P., & Yin, T. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.12.007 · Cited by 45
Horenstein, R. B., Madabushi, R., Zineh, I., Yerges‐Armstrong, L. M., Peer, C. J., Schuck, R. N., Figg, W. D., Shuldiner, A. R., & Pacanowski, M. A. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.293 · Cited by 37
Self-citationCarreras, E. T., Hochholzer, W., Frelinger, A. L., Nordio, F., O’Donoghue, M. L., Wiviott, S. D., Angiolillo, D. J., Michelson, A. D., Sabatine, M. S., & Mega, J. L. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-12-0981 · Cited by 32
Self-citationScott, S. A., Collet, J. ‐., Baber, U., Yang, Y., Peter, I., Linderman, M. D., Sload, J., Qiao, W., Kini, A. S., Sharma, S., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.401 · Cited by 31
Self-citationClaassens, D. M. F., Bergmeijer, T. O., Vos, G. J. A., Hermanides, R. S., Hof, A. W. J. V. ’., van der Harst, P., Barbato, E., Morisco, C., Gin, M. T. J., Asselbergs, F. W., et al. (2021) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.009434 · Cited by 28
Structural variation at the CYP2C locus: Characterization of deletion and duplication alleles
Botton, M. R., Lu, X., Zhao, G., Repnikova, E. A., Seki, Y., Gaedigk, A., Schadt, E. E., Edelmann, L. J., & Scott, S. A. (2019) · Human Mutation · doi:10.1002/humu.23855 · Cited by 23
Self-citation
Cited by
Villapalos-García, G., Zubiaur, P., Marián-Revilla, C., Soria-Chacartegui, P., Navares-Gómez, M., Mejía-Abril, G., Rodríguez-Lopez, A., González-Iglesias, E., Martín-Vílchez, S., Román, M., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111566 · Cited by 4
Metadata
- Authors
- Lee, C. R., Luzum, J. A., Sangkuhl, K., Gammal, R. S., Sabatine, M. S., Stein, C. M., Kisor, D. F., Limdi, N. A., Lee, Y. M., Scott, S. A., Hulot, J., Roden, D. M., Gaedigk, A., Caudle, K. E., Klein, T. E., Johnson, J. A., & Shuldiner, A. R.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2022-02-08
- Volume
- 112
- Issue
- 5
- Pages
- 959-967
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W4205713819
- Cited by
- 519
- References
- 38
- FWCI
- 76.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.